Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 496

1.

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.

Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W; Pediatric AIDS Clinical Trials Group 1008 Team.

J Infect Dis. 2006 Jan 15;193(2):302-11. Epub 2005 Dec 7.

PMID:
16362896
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.

Lee CY, Huang LM, Lee PI, Chiu HH, Dumas R, Milcamps B, Lin W.

Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):29-36.

PMID:
11023061
[PubMed - indexed for MEDLINE]
3.

Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study.

Launay O, Grabar S, Gordien E, Desaint C, Jegou D, Abad S, Girard PM, Bélarbi L, Guérin C, Dimet J, Williams V, Krivine A, Salmon D, Lortholary O, Rey D; HEPAVAC Study Group1.

J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):272-5. doi: 10.1097/QAI.0b013e318183a9c0.

PMID:
18845961
[PubMed - indexed for MEDLINE]
4.

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.

Weinberg A, Huang S, Fenton T, Patterson-Bartlett J, Gona P, Read JS, Dankner WM, Nachman S; IMPAACT P1008 Team.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):17-24. doi: 10.1097/QAI.0b013e3181b011f6.

PMID:
19617848
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Warshaw M, Rosenblatt HM, Levin MJ, Nachman SA, Pelton SI, Borkowsky W, Fenton T; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams.

J Infect Dis. 2009 Sep 15;200(6):935-46. doi: 10.1086/605448.

PMID:
19663708
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
[PubMed - indexed for MEDLINE]
7.

Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine.

Beck BR, Hatz CF, Loutan L, Steffen R.

J Travel Med. 2004 Jul-Aug;11(4):201-6.

PMID:
15541221
[PubMed - indexed for MEDLINE]
8.

Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.

Saksawad R, Likitnukul S, Warachit B, Hanvivatvong O, Poovorawan Y, Puripokai P.

Vaccine. 2011 Jun 24;29(29-30):4735-8. doi: 10.1016/j.vaccine.2011.04.091. Epub 2011 May 12.

PMID:
21570433
[PubMed - indexed for MEDLINE]
9.

Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents.

Siberry GK, Coller RJ, Henkle E, Kiefner C, Joyner M, Rogers J, Chang J, Hutton N.

Pediatr Infect Dis J. 2008 May;27(5):465-8. doi: 10.1097/INF.0b013e31816454a3.

PMID:
18382387
[PubMed - indexed for MEDLINE]
10.

Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.

Abarca K, Ibánez I, Perret C, Vial P, Zinsou JA.

Int J Infect Dis. 2008 May;12(3):270-7. Epub 2007 Nov 7.

PMID:
17988917
[PubMed - indexed for MEDLINE]
Free Article
11.

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 Protocol Team.

Pediatrics. 2007 Nov;120(5):e1190-202. Epub 2007 Oct 15.

PMID:
17938165
[PubMed - indexed for MEDLINE]
Free Article
12.

Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.

Lagos R, Munoz A, Dumas R, Pichon S, Zambrano B, Levine M, Vidor E.

Vaccine. 2003 Sep 8;21(25-26):3730-3.

PMID:
12922104
[PubMed - indexed for MEDLINE]
13.

Antibody responses to hepatitis A virus vaccination in thai hiv-infected children with immune recovery after antiretroviral therapy.

Sudjaritruk T, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2011 Mar;30(3):256-9. doi: 10.1097/INF.0b013e3181f812f8.

PMID:
20856163
[PubMed - indexed for MEDLINE]
14.

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.

Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B; Pediatric AIDS Clinical Trials Group 265 Team.

J Infect Dis. 2006 Jul 15;194(2):247-55. Epub 2006 Jun 14.

PMID:
16779732
[PubMed - indexed for MEDLINE]
Free Article
15.

Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.

Ambrosch F, Finkel B, Herzog C, Koren A, Kollaritsch H.

Infection. 2004 Jun;32(3):149-52. Erratum in: Infection. 2004 Aug;32(4):249.

PMID:
15188074
[PubMed - indexed for MEDLINE]
16.

Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.

Soysal A, Gokçe I, Pehlivan T, Bakir M.

Eur J Pediatr. 2007 Jun;166(6):533-9. Epub 2007 Feb 22.

PMID:
17318620
[PubMed - indexed for MEDLINE]
17.

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I; Pediatric AIDS Clinical Trials Group P1024 Protocol Team.

Pediatr Infect Dis J. 2006 Oct;25(10):920-9.

PMID:
17006288
[PubMed - indexed for MEDLINE]
18.

Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children.

López EL, Del Carmen Xifró M, Torrado LE, De Rosa MF, Gómez R, Dumas R, Wood SC, Contrini MM.

Pediatr Infect Dis J. 2001 Jan;20(1):48-52.

PMID:
11176566
[PubMed - indexed for MEDLINE]
19.

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.

Castillo de Febres O, Chacon de Petrola M, Casanova de Escalona L, Naveda O, Naveda M, Estopinan M, Bordones G, Zambrano B, Garcia A, Dumas R.

Vaccine. 1999 Nov 12;18(7-8):656-64.

PMID:
10547425
[PubMed - indexed for MEDLINE]
20.

Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.

D'Acremont V, Herzog C, Genton B.

J Travel Med. 2006 Mar-Apr;13(2):78-83.

PMID:
16553593
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk